Why it was recalled
Lack of Assurance of Sterility
Product description
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Lot numbers, UPCs & expiration codes
Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.
Where it was sold
Nationwide in the USA.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0870-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Sep 15, 2026
- FDA report date
- Sep 30, 2026
- Quantity
- 2,356,248 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Original FDA data
Every field from FDA enforcement report D-0870-2026, exactly as published.
Show all FDA fields
- City
- Tarrytown
- State
- NY
- Status
- Ongoing
- Country
- United States
- Event ID
- 99909
- Address
- 660 White Plains Rd Ste 250
- Code information
- Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.
- Postal code
- 10591-5171
- Report date
- Sep 30, 2026
- Product type
- Drugs
- Recall number
- D-0870-2026
- Classification
- Class II
- Recalling firm
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
- Product quantity
- 2,356,248 bottles
- Reason for recall
- Lack of Assurance of Sterility
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
- Distribution pattern
- Nationwide in the USA.
- Recall initiation date
- Sep 15, 2026
- Initial firm notification
- Letter
- Center classification date
- Sep 23, 2026